UCB (Union chimique belge) - Company & Market Research Reports

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023 - Product Thumbnail Image

Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023

  • Report
  • 120 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Cimzia 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Cimzia 2017 U.S. Promotional Audit Report

  • Report
  • 22 Pages
From
Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
Oncology Drug Discovery Services Market, 2017-2030 - Product Thumbnail Image

Oncology Drug Discovery Services Market, 2017-2030

  • Report
  • 270 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
Drugs for Rheumatoid Arthritis: Global Markets to 2022 - Product Thumbnail Image

Drugs for Rheumatoid Arthritis: Global Markets to 2022

  • Report
  • 182 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Rheumatoid Arthritis Therapeutics Market Size Analysis Report By Molecule Type, By Sales Channel (Prescription, OTC), And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics Market Size Analysis Report By Molecule Type, By Sales Channel (Prescription, OTC), And Segment Forecasts, 2018 - 2025

  • Report
  • 85 Pages
From
Sjögren's Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments - Product Thumbnail Image

Sjögren's Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • Report
  • 106 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020 - Product Thumbnail Image

Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

  • Report
  • 98 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Myasthenia Gravis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Myasthenia Gravis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 90 Pages
From
CD Antigen Cancer Therapy Market Outlook & Clinical Trials Insight 2023 - Product Thumbnail Image

CD Antigen Cancer Therapy Market Outlook & Clinical Trials Insight 2023

  • Report
  • 500 Pages
From
Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 68 Pages
From
Global Lupus Therapeutic Market 2017-2021 - Product Thumbnail Image

Global Lupus Therapeutic Market 2017-2021

  • Report
  • 82 Pages
From
Global Rheumatoid Arthritis Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Rheumatoid Arthritis Market Analysis 2016 - Forecast to 2022

  • Report
  • 134 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Loading Indicator
adroll